Teleflex Incorporated (NYSE:TFX) Director Stuart A. Randle Purchases 1,000 Shares

Key Points

• Teleflex Incorporated Director Stuart A. Randle purchased 1,000 shares of the company at an average price of $115.86 per share, increasing his position by 15.27%.
• The company reported a quarterly earnings per share of $3.73, exceeding analyst expectations, with revenue reaching $780.90 million, a 4.2% increase year-over-year.
• Teleflex has declared a quarterly dividend of $0.34 per share, representing a 1.2% dividend yield and a dividend payout ratio of 32%.

Teleflex Incorporated (NYSE:TFX - Get Free Report) Director Stuart A. Randle acquired 1,000 shares of Teleflex stock in a transaction dated Tuesday, August 5th. The shares were bought at an average cost of $115.86 per share, for a total transaction of $115,860.00. Following the completion of the purchase, the director directly owned 7,547 shares of the company's stock, valued at approximately $874,395.42. The trade was a 15.27% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Teleflex Stock Down 1.5%

Shares of TFX traded down $1.77 during mid-day trading on Monday, reaching $116.64. The company had a trading volume of 46,054 shares, compared to its average volume of 801,603. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. The firm has a 50-day moving average price of $118.09 and a 200 day moving average price of $134.28. Teleflex Incorporated has a 52 week low of $108.90 and a 52 week high of $249.90. The company has a market capitalization of $5.15 billion, a price-to-earnings ratio of 27.52, a price-to-earnings-growth ratio of 1.65 and a beta of 1.08.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 EPS for the quarter, topping analysts' consensus estimates of $3.36 by $0.37. Teleflex had a return on equity of 15.08% and a net margin of 6.31%. The firm had revenue of $780.90 million for the quarter, compared to analysts' expectations of $771.53 million. During the same period in the previous year, the firm posted $3.42 EPS. The business's revenue for the quarter was up 4.2% compared to the same quarter last year. On average, sell-side analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Friday, August 15th will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend is Friday, August 15th. Teleflex's dividend payout ratio (DPR) is currently 32.00%.

Wall Street Analyst Weigh In

Several research analysts have commented on TFX shares. Mizuho upped their price objective on shares of Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a report on Friday, August 1st. Wells Fargo & Company cut their price objective on Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a research report on Friday, August 1st. Morgan Stanley cut their price objective on Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a research report on Monday, May 5th. Truist Financial cut their price objective on Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a research report on Monday, May 5th. Finally, Wall Street Zen raised Teleflex from a "hold" rating to a "strong-buy" rating in a research report on Saturday, August 2nd. One analyst has rated the stock with a sell rating, eight have issued a hold rating, one has issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Teleflex currently has a consensus rating of "Hold" and a consensus price target of $141.57.

Hedge Funds Weigh In On Teleflex

A number of institutional investors have recently bought and sold shares of the stock. Headlands Technologies LLC bought a new stake in shares of Teleflex during the 4th quarter valued at $29,000. Banque Cantonale Vaudoise bought a new stake in Teleflex during the first quarter valued at about $27,000. MassMutual Private Wealth & Trust FSB raised its holdings in Teleflex by 103.1% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock valued at $27,000 after acquiring an additional 100 shares during the period. Costello Asset Management INC bought a new stake in Teleflex during the first quarter valued at about $28,000. Finally, Brooklyn Investment Group raised its holdings in Teleflex by 258.6% during the first quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company's stock valued at $29,000 after acquiring an additional 150 shares during the period. 95.62% of the stock is owned by institutional investors.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.